$CSL
CARLISLE COMPANIES INC

2024 Q3 Form 10-Q Financial Statement

#000079005124000166 Filed on July 25, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $1.334B $1.451B
YoY Change 5.86% -4.93%
Cost Of Revenue $819.2M $881.7M
YoY Change 3.21% -11.35%
Gross Profit $514.4M $568.9M
YoY Change 10.36% 7.08%
Gross Profit Margin 38.57% 39.22%
Selling, General & Admin $191.8M $189.3M
YoY Change 18.61% -0.05%
% of Gross Profit 37.29% 33.27%
Research & Development $8.100M $9.300M
YoY Change 12.5% -29.01%
% of Gross Profit 1.57% 1.63%
Depreciation & Amortization $44.60M $43.10M
YoY Change -11.33% -26.32%
% of Gross Profit 8.67% 7.58%
Operating Expenses $199.9M $198.6M
YoY Change 18.35% -1.93%
Operating Profit $316.4M $377.5M
YoY Change 5.5% 14.81%
Interest Expense $4.000M -$5.000M
YoY Change -79.38% -65.03%
% of Operating Profit 1.26% -1.32%
Other Income/Expense, Net $1.100M $100.0K
YoY Change -283.33% -150.0%
Pretax Income $321.5M $372.6M
YoY Change 13.4% 19.0%
Income Tax $74.90M $87.40M
% Of Pretax Income 23.3% 23.46%
Net Earnings $244.3M $712.4M
YoY Change -8.02% 266.08%
Net Earnings / Revenue 18.32% 49.11%
Basic Earnings Per Share $5.31 $15.03
Diluted Earnings Per Share $5.25 $14.84
COMMON SHARES
Basic Shares Outstanding 46.24M shares 47.60M shares
Diluted Shares Outstanding 46.50M shares 47.90M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.531B $1.736B
YoY Change 1317.22% 357.76%
Cash & Equivalents $1.531B $1.736B
Short-Term Investments
Other Short-Term Assets $91.50M $64.10M
YoY Change -10.99% -90.49%
Inventory $462.4M $426.3M
Prepaid Expenses $27.70M $21.80M
Receivables $799.2M $903.6M
Other Receivables $0.00 $0.00
Total Short-Term Assets $2.911B $3.152B
YoY Change -20.39% 17.05%
LONG-TERM ASSETS
Property, Plant & Equipment $670.7M $664.2M
YoY Change 6.94% -16.85%
Goodwill $1.342B $1.337B
YoY Change 13.94% -33.74%
Intangibles $1.426B $1.450B
YoY Change 12.92% -6.58%
Long-Term Investments
YoY Change
Other Assets $128.4M $124.8M
YoY Change 40.64% 9.19%
Total Long-Term Assets $3.567B $3.576B
YoY Change 12.92% -20.23%
TOTAL ASSETS
Total Short-Term Assets $2.911B $3.152B
Total Long-Term Assets $3.567B $3.576B
Total Assets $6.478B $6.728B
YoY Change -4.95% -6.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $327.3M $363.4M
YoY Change -0.33% -8.51%
Accrued Expenses $310.4M $296.3M
YoY Change 22.2% 21.38%
Deferred Revenue $27.70M $27.10M
YoY Change 7.78% 0.37%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $403.0M $402.9M
YoY Change 17421.74% 33.41%
Total Short-Term Liabilities $1.068B $1.090B
YoY Change 22.02% 4.25%
LONG-TERM LIABILITIES
Long-Term Debt $1.887B $1.887B
YoY Change -17.34% -17.31%
Other Long-Term Liabilities $444.4M $439.0M
YoY Change 0.02% -46.25%
Total Long-Term Liabilities $2.647B $2.634B
YoY Change -12.25% -14.99%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.068B $1.090B
Total Long-Term Liabilities $2.647B $2.634B
Total Liabilities $3.716B $3.724B
YoY Change -4.54% -10.14%
SHAREHOLDERS EQUITY
Retained Earnings $6.655B $6.457B
YoY Change 21.68% 23.08%
Common Stock $659.4M $649.0M
YoY Change 5.83% 6.34%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.763B $3.004B
YoY Change
Total Liabilities & Shareholders Equity $6.478B $6.728B
YoY Change -4.95% -6.24%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $244.3M $712.4M
YoY Change -8.02% 266.08%
Depreciation, Depletion And Amortization $44.60M $43.10M
YoY Change -11.33% -26.32%
Cash From Operating Activities $312.8M $183.4M
YoY Change -29.18% -17.05%
INVESTING ACTIVITIES
Capital Expenditures $19.30M $24.90M
YoY Change -46.69% -16.72%
Acquisitions
YoY Change
Other Investing Activities $1.600M $1.584B
YoY Change -70.37% 27680.7%
Cash From Investing Activities -$17.70M $1.559B
YoY Change -42.53% -6540.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -501.0M -575.8M
YoY Change -24.93% 147.87%
NET CHANGE
Cash From Operating Activities 312.8M 183.4M
Cash From Investing Activities -17.70M 1.559B
Cash From Financing Activities -501.0M -575.8M
Net Change In Cash -205.9M 1.166B
YoY Change -19.73% -3394.35%
FREE CASH FLOW
Cash From Operating Activities $312.8M $183.4M
Capital Expenditures $19.30M $24.90M
Free Cash Flow $293.5M $158.5M
YoY Change -27.62% -17.1%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
700000000.0 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
250000000.0 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
81700000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
77200000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
61200000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
11800000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
10000000.0 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-3900000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-1700000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-741900000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-327100000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-800000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
800000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1130800000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-11500000 usd
us-gaap Net Cash Provided By Used In Discontinued Operations
NetCashProvidedByUsedInDiscontinuedOperations
-28800000 usd
us-gaap Net Cash Provided By Used In Discontinued Operations
NetCashProvidedByUsedInDiscontinuedOperations
4100000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
576700000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
364800000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
3058300000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
194600000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-900000 usd
CY2023Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.75
CY2023Q2 us-gaap Dividends Cash
DividendsCash
38300000 usd
CY2024Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.85
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.5
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.7
CY2024Q2 csl Percentage Of Undistributed Earnings Allocated To Common Shareholders
PercentageOfUndistributedEarningsAllocatedToCommonShareholders
0.998
CY2024Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P6M
CY2024Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2024Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2024Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2024Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2024Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2024Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2023Q4 csl Preferred Stock Shares Unissued
PreferredStockSharesUnissued
5000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
22000000.0 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
22000000.0 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
17500000 usd
CY2023Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
201900000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
285200000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
226700000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
456100000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
310300000 usd
CY2024Q2 us-gaap Dividends
Dividends
40300000 usd
CY2023Q2 us-gaap Dividends
Dividends
38300000 usd
us-gaap Dividends
Dividends
81800000 usd
us-gaap Dividends
Dividends
77300000 usd
CY2024Q2 us-gaap Undistributed Earnings
UndistributedEarnings
244900000 usd
CY2023Q2 us-gaap Undistributed Earnings
UndistributedEarnings
188400000 usd
us-gaap Undistributed Earnings
UndistributedEarnings
374300000 usd
us-gaap Undistributed Earnings
UndistributedEarnings
233000000.0 usd
CY2023Q2 csl Percentage Of Undistributed Earnings Allocated To Common Shareholders
PercentageOfUndistributedEarningsAllocatedToCommonShareholders
0.998
csl Percentage Of Undistributed Earnings Allocated To Common Shareholders
PercentageOfUndistributedEarningsAllocatedToCommonShareholders
0.998
csl Percentage Of Undistributed Earnings Allocated To Common Shareholders
PercentageOfUndistributedEarningsAllocatedToCommonShareholders
0.998
CY2024Q2 us-gaap Undistributed Earnings Loss Available To Common Shareholders Basic
UndistributedEarningsLossAvailableToCommonShareholdersBasic
244400000 usd
CY2023Q2 us-gaap Undistributed Earnings Loss Available To Common Shareholders Basic
UndistributedEarningsLossAvailableToCommonShareholdersBasic
188000000.0 usd
us-gaap Undistributed Earnings Loss Available To Common Shareholders Basic
UndistributedEarningsLossAvailableToCommonShareholdersBasic
373600000 usd
us-gaap Undistributed Earnings Loss Available To Common Shareholders Basic
UndistributedEarningsLossAvailableToCommonShareholdersBasic
232500000 usd
CY2024Q2 us-gaap Dividends Common Stock
DividendsCommonStock
40200000 usd
CY2023Q2 us-gaap Dividends Common Stock
DividendsCommonStock
38200000 usd
us-gaap Dividends Common Stock
DividendsCommonStock
81600000 usd
us-gaap Dividends Common Stock
DividendsCommonStock
77100000 usd
CY2024Q2 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
284600000 usd
CY2023Q2 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
226200000 usd
us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
455200000 usd
us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
309600000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47300000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50700000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47500000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50900000 shares
CY2024Q2 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
200000 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
200000 shares
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
200000 shares
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
100000 shares
CY2024Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
400000 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
300000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
500000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
400000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47900000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51200000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48200000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51400000 shares
CY2024Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
6.02
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
4.46
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
9.58
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
6.08
CY2024Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
5.94
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
4.42
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
9.45
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
6.02
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47300000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50700000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47500000 shares
CY2024Q2 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
47400000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
50800000 shares
us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
47600000 shares
us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
51000000.0 shares
CY2024Q2 csl Percentage Of Undistributed Earnings Allocated To Common Shareholders
PercentageOfUndistributedEarningsAllocatedToCommonShareholders
0.998
CY2023Q2 csl Percentage Of Undistributed Earnings Allocated To Common Shareholders
PercentageOfUndistributedEarningsAllocatedToCommonShareholders
0.998
csl Percentage Of Undistributed Earnings Allocated To Common Shareholders
PercentageOfUndistributedEarningsAllocatedToCommonShareholders
0.998
csl Percentage Of Undistributed Earnings Allocated To Common Shareholders
PercentageOfUndistributedEarningsAllocatedToCommonShareholders
0.998
CY2024Q2 us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Diluted
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted
426300000 usd
CY2024Q2 us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
426300000 usd
CY2023Q2 us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
-32100000 usd
CY2023Q2 us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Diluted
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted
-32100000 usd
us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Diluted
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted
447700000 usd
us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
447700000 usd
us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Diluted
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted
-14000000.0 usd
us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
-14000000.0 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
711100000 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
711100000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
194100000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
194100000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
903000000.0 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
903000000.0 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
295600000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
295600000 usd
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000 shares
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
800000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
800000 shares
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
14000000.0 usd
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
27200000 usd
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
26200000 usd
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
25200000 usd
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
24100000 usd
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
23100000 usd
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
195400000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
324000000.0 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
294800000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
14100000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
13200000 usd
csl Contract With Customer Liability Revenue Deferred In Period
ContractWithCustomerLiabilityRevenueDeferredInPeriod
25300000 usd
csl Contract With Customer Liability Revenue Deferred In Period
ContractWithCustomerLiabilityRevenueDeferredInPeriod
25700000 usd
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
335200000 usd
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
307300000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1450600000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1307000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2547100000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2199600000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1450600000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1307000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2547100000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2199600000 usd
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7900000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7800000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
17600000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
16800000 usd
CY2024Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
900000 usd
CY2023Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1200000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1800000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
2400000 usd
CY2024Q2 csl Share Based Payment Arrangement Amortization Of Capitalized Cost
ShareBasedPaymentArrangementAmortizationOfCapitalizedCost
900000 usd
CY2023Q2 csl Share Based Payment Arrangement Amortization Of Capitalized Cost
ShareBasedPaymentArrangementAmortizationOfCapitalizedCost
1200000 usd
csl Share Based Payment Arrangement Amortization Of Capitalized Cost
ShareBasedPaymentArrangementAmortizationOfCapitalizedCost
1900000 usd
csl Share Based Payment Arrangement Amortization Of Capitalized Cost
ShareBasedPaymentArrangementAmortizationOfCapitalizedCost
2500000 usd
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
7900000 usd
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
7800000 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
17700000 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
16900000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.224
csl Expected Effective Income Tax Rate Continuing Operations
ExpectedEffectiveIncomeTaxRateContinuingOperations
0.238
csl Discrete Income Tax Expense Benefit
DiscreteIncomeTaxExpenseBenefit
-8600000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.229
CY2024Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
148200000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
120900000 usd
CY2024Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
25500000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
26200000 usd
CY2024Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
262100000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
222500000 usd
CY2024Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
9500000 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
7900000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
426300000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
361700000 usd
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
77200000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
77200000 usd
CY2024Q2 csl Accrued Customer Incentives Current
AccruedCustomerIncentivesCurrent
75600000 usd
CY2023Q4 csl Accrued Customer Incentives Current
AccruedCustomerIncentivesCurrent
112700000 usd
CY2024Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
25900000 usd
CY2023Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
24900000 usd
CY2024Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
53900000 usd
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
19900000 usd
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
63700000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
58200000 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
296300000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
292900000 usd
CY2023Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
24900000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
25200000 usd
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
10300000 usd
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
6700000 usd
us-gaap Standard Product Warranty Accrual Additions From Business Acquisition
StandardProductWarrantyAccrualAdditionsFromBusinessAcquisition
800000 usd
us-gaap Standard Product Warranty Accrual Additions From Business Acquisition
StandardProductWarrantyAccrualAdditionsFromBusinessAcquisition
0 usd
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
10000000.0 usd
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
7100000 usd
us-gaap Standard Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardProductWarrantyAccrualForeignCurrencyTranslationGainLoss
100000 usd
us-gaap Standard Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardProductWarrantyAccrualForeignCurrencyTranslationGainLoss
-100000 usd
CY2024Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
25900000 usd
CY2023Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
24900000 usd
CY2024Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
9900000 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
10600000 usd
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
2290100000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
2289400000 usd
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
402900000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
402700000 usd
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1887200000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1886700000 usd
CY2024Q2 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
23300000 usd
CY2023Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
17600000 usd
CY2024Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
20000000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
19800000 usd
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000790051-24-000166-index-headers.html Edgar Link pending
0000790051-24-000166-index.html Edgar Link pending
0000790051-24-000166.txt Edgar Link pending
0000790051-24-000166-xbrl.zip Edgar Link pending
csl-20240630.htm Edgar Link pending
csl-20240630.xsd Edgar Link pending
csl-20240630_g1.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
palmer-amendmenttospaexecu.htm Edgar Link pending
q22024-exhibit311form10xq.htm Edgar Link pending
q22024-exhibit312form10xq.htm Edgar Link pending
q22024-exhibit321form10xq.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
csl-20240630_cal.xml Edgar Link unprocessable
csl-20240630_def.xml Edgar Link unprocessable
csl-20240630_lab.xml Edgar Link unprocessable
csl-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
csl-20240630_htm.xml Edgar Link completed
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending